Starling Oncology, Inc. (STLN)
NASDAQ: STLN · Real-Time Price · USD
6.13
-0.34 (-5.26%)
At close: Aug 24, 2026, 4:00 PM EDT
6.14
+0.01 (0.16%)
After-hours: Aug 24, 2026, 7:30 PM EDT
Starling Oncology Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Starling Oncology stock has a consensus rating of "Strong Buy" and an average price target of $9.00. The average 1-year stock price forecast is 46.82% higher than the current stock price, while the lowest is $7.00 (+14.19%) and the highest is $11 (+79.45%).
Price Target: $9.00 (+46.82%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Starling Oncology stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 4 | 4 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Buy Reiterates $7 | Buy | Reiterates | $7 | +14.19% | Aug 7, 2026 |
| B. Riley Securities | B. Riley Securities | Buy Maintains $8 → $11 | Buy | Maintains | $8 → $11 | +79.45% | Aug 7, 2026 |
| BTIG | BTIG | Buy Maintains $8 → $9 | Buy | Maintains | $8 → $9 | +46.82% | Jul 16, 2026 |
| Lake Street | Lake Street | Buy Initiates $10 | Buy | Initiates | $10 | +63.13% | Jul 6, 2026 |
| Noble Financial | Noble Financial | Buy Reiterates $8 | Buy | Reiterates | $8 | +30.51% | May 8, 2026 |
Financial Forecast
Revenue This Year
665.01M
from 502.73M
Increased by 32.28%
Revenue Next Year
883.97M
from 665.01M
Increased by 32.92%
EPS This Year
n/a
EPS Next Year
n/a